Cannabidiol inhibits synaptic transmission in rat hippocampal cultures and slices via multiple receptor pathways.
OBJECTIVE
Cannabidiol (CBD) has emerged as an interesting compound with therapeutic potential in several CNS disorders. However, whether it can modulate synaptic activity in the CNS remains unclear. Here, we have investigated whether CBD modulates synaptic transmission in rat hippocampal cultures and acute slices.


METHODS
The effect of CBD on synaptic transmission was examined in rat hippocampal cultures and acute slices using whole cell patch clamp and standard extracellular recordings respectively.


RESULTS
Cannabidiol decreased synaptic activity in hippocampal cultures in a concentration-dependent and Pertussis toxin-sensitive manner. The effects of CBD in culture were significantly reduced in the presence of the cannabinoid receptor (CB(1) ) inverse agonist, LY320135 but were unaffected by the 5-HT(1A) receptor antagonist, WAY100135. In hippocampal slices, CBD inhibited basal synaptic transmission, an effect that was abolished by the proposed CB(1) receptor antagonist, AM251, in addition to LY320135 and WAY100135.


CONCLUSIONS
Cannabidiol reduces synaptic transmission in hippocampal in vitro preparations and we propose a role for both 5-HT(1A) and CB(1) receptors in these CBD-mediated effects. These data offer some mechanistic insights into the effects of CBD and emphasize that further investigations into the actions of CBD in the CNS are required in order to elucidate the full therapeutic potential of CBD.
Ledgerwood
C J
CJ
Strathclyde Institute of Pharmacy and Biological Sciences, University of Strathclyde, Glasgow, UK.
Greenwood
S M
SM
Brett
R R
RR
Pratt
J A
JA
Bushell
T J
TJ
D000818:Animals; D002185:Cannabidiol / Q000494:pharmacology*; D002478:Cells, Cultured; D006624:Hippocampus / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism / Q000502:physiology; D066298:In Vitro Techniques; D009474:Neurons / Q000187:drug effects / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D043882:Receptors, Cannabinoid / Q000378:metabolism*; D009435:Synaptic Transmission / Q000187:drug effects*
D043882:Receptors, Cannabinoid; D002185:Cannabidiol
J Ethnopharmacol. 2006 Apr 21;105(1-2):1-25
16540272
J Pharmacol Exp Ther. 2008 Jun;325(3):1007-15
18354058
Science. 1994 Apr 1;264(5155):107-11
7832825
Br J Pharmacol. 2008 Jan;153(2):199-215
17828291
Psychopharmacology (Berl). 2008 Aug;199(2):223-30
18446323
Neuropsychopharmacology. 2008 Sep;33(10):2505-16
18185500
J Neurosci Res. 2009 Feb 15;87(3):766-75
18816788
Cell Calcium. 2005 Sep-Oct;38(3-4):369-74
16085309
Annu Rev Cell Dev Biol. 2000;16:521-55
11031246
Br J Pharmacol. 2010 Jan;159(1):122-8
20002102
Br J Pharmacol. 2009 Nov;158 Suppl 1:S1-254
19883461
Neuropsychopharmacology. 2010 Feb;35(3):764-74
19924114
Expert Opin Pharmacother. 2010 Jan;11(1):17-31
20001426
Mol Pharmacol. 2009 Apr;75(4):892-900
19118122
Med Hypotheses. 2006;66(2):234-46
16209908
J Biol Chem. 2008 Jun 6;283(23):16124-34
18390906
Cell Calcium. 2002 Nov-Dec;32(5-6):405-11
12543099
Trends Pharmacol Sci. 2009 Oct;30(10):515-27
19729208
J Pharmacol Exp Ther. 2000 Mar;292(3):960-7
10688610
J Neurosci. 1995 Nov;15(11):7217-25
7472476
J Physiol. 2005 Dec 1;569(Pt 2):501-17
16179366
Neurochem Res. 2005 Aug;30(8):1037-43
16258853
Br J Pharmacol. 2007 Mar;150(5):613-23
17245363
Mol Pharmacol. 1999 Jan;55(1):8-13
9882692
Hippocampus. 2007;17(4):316-25
17330864
J Neurosci. 2008 Jun 11;28(24):6231-8
18550765
J Biol Chem. 2007 Sep 7;282(36):26235-44
17616519
Trends Cogn Sci. 2006 Apr;10(4):167-74
16531099
Int J Neuropsychopharmacol. 2010 May;13(4):421-32
19775500
Br J Pharmacol. 2009 Jan;156(1):181-8
19133999
J Pharmacol Exp Ther. 2010 Feb;332(2):569-77
19906779
Mol Neurobiol. 1998 Winter;17(1-3):59-72
9887446
J Neurophysiol. 1994 Jun;71(6):2570-5
7931538
J Neurosci. 2007 Jan 31;27(5):1211-9
17267577
J Neurosci. 1988 Apr;8(4):1273-85
2965756
J Neurosci. 2009 Feb 18;29(7):2053-63
19228959
J Physiol. 1991 Dec;444:687-701
1668353
Life Sci. 2005 Feb 4;76(12):1307-24
15670612
Neuropharmacology. 2006 Apr;50(5):621-31
16386766
J Physiol. 1987 Dec;394:99-124
3443977
Br J Pharmacol. 2001 Oct;134(4):845-52
11606325
Arch Gen Psychiatry. 2009 Apr;66(4):442-51
19349314
J Pharmacol Exp Ther. 1996 Sep;278(3):989-99
8819477
Br J Pharmacol. 1998 May;124(1):93-100
9630348
J Neurosci. 2002 Jul 15;22(14):5840-7
12122046